Jonathan joined Imperial Innovations in 2011 and specialises in therapeutics and diagnostics investments. He is a board director with diagnostics companies Abingdon Health and Molecular Vision, and a board observer with Cell Medica. Prior to joining Imperial Innovations he worked at MRC Technology, sourcing and evaluating new opportunities for small molecule and antibody drug discovery worldwide. He has a PhD in molecular medicine from UCL, and undertook post-doctoral research at the Cancer Research UK LRI. Jonathan has a First Class degree in Biology from Oxford University and an MBA with Distinction from Imperial College.
Developing cell based products for immune reconstitution and ...Find out more
Innovative therapeutics for serious diseases with a particular ...Find out more
Developer and distributer of state-of-the-art diagnostic tools and ...Find out more